60 Degrees Pharmaceuticals
(NASDAQ) SXTP
60 Degrees Pharmaceuticals Financials at a Glance
Market Cap
$4.49M
Revenue (TTM)
$1.00M
Net Income (TTM)
-$7.58M
EPS (TTM)
-$10.29
P/E Ratio
-0.16
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.69
Volume
19,030
Open
$1.69
Price
$1.69
Volume
19,030
Open
$1.69
Previous Close
$1.69
Daily Range
$1.65 - $1.70
52-Week Range
$1.22 - $10.77
Estimated Earnings Date
Aug 12, 2026
Dividend
$0.00
Beta (Volatility)
0.00 (Low)
Price
$1.69
Volume
19,030
Open
$1.69
Previous Close
$1.69
Daily Range
$1.65 - $1.70
52-Week Range
$1.22 - $10.77
Estimated Earnings Date
Aug 12, 2026
SXTP News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout 60 Degrees Pharmaceuticals
Industry
Pharmaceuticals
Sector
Health CareEmployees
5
CEO
Geoffrey S. Dow, PhD, MBA
Website
60degreespharma.comHeadquarters
Washington, DC 20036, US
SXTP Financials
Key Financial Metrics (TTM)
Gross Margin
20.90%
Operating Margin
-791.09%
Net Income Margin
-755.16%
Return on Equity
-200.17%
Return on Capital
-214.57%
Return on Assets
-112.10%
Earnings Yield
-6.25%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$4.49M
Shares Outstanding
2.66M
Volume
19.03K
Avg. Volume
153.92K
Financials (TTM)
Gross Profit
$209.87K
Operating Income
-$7.94M
EBITDA
-$7.49M
Operating Cash Flow
-$7.99M
Capital Expenditure
-$222.75K
Free Cash Flow
-$8.22M
Cash & ST Invst.
$3.34M
Total Debt
$151.97K
60 Degrees Pharmaceuticals Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$162.09K
-0.9%
Gross Profit
$76.38K
-15.4%
Gross Margin
47.12%
N/A
Market Cap
$4.49M
N/A
Market Cap/Employee
$1.50M
N/A
Employees
3
N/A
Net Income
-$2.09M
-11.4%
EBITDA
-$2.07M
-11.3%
Quarterly Fundamentals
Total Cash
$3.34M
-3.3%
Total Debt
$151.97K
-2.1%
Accounts Receivable
$335.84K
-31.2%
Inventory
$910.60K
+17.8%
Long Term Debt
$143.20K
-2.3%
Short Term Debt
$8.77K
+0.0%
Return on Assets
-1.12%
N/A
Return on Invested Capital
-1.63%
N/A
Free Cash Flow
-$2.77M
-72.9%
Operating Cash Flow
-$2.74M
-71.6%